StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.69+0.07 (+4.32%)

Close on Nov 18, 2026Market cap $1.26BP/E –Yield –

OPKO Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

OPKO Health's operating income for the twelve months ending Jun 30, 2026 was -$48.25M. For fiscal 2025 it was -$117.41M. The highest annual figure on record is $57.71M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$117.41M–
FY2024Dec 31, 2024-$152.07M–
FY2023Dec 31, 2023-$157.02M–
FY2022Dec 31, 2022-$226.25M-1306.7%
FY2021Dec 31, 2021$18.75M-67.5%
FY2020Dec 31, 2020$57.71M–
FY2019Dec 31, 2019-$274.05M–
FY2018Dec 31, 2018-$171.20M–
FY2017Dec 31, 2017-$276.44M–
FY2016Dec 31, 2016-$96.55M–
FY2015Dec 31, 2015-$98.48M–
FY2014Dec 31, 2014-$145.82M–
FY2013Dec 31, 2013-$79.63M–
FY2012Dec 31, 2012-$37.27M–
FY2011Dec 31, 2011-$23.19M–
FY2010Dec 31, 2010-$11.14M–
FY2009Dec 31, 2009-$22.15M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.97M–
Q1 FY2026Mar 31, 2026-$51.02M–
Q4 FY2025Dec 31, 2025-$38.32M–
Q3 FY2025Sep 30, 2025$48.06M–
Q2 FY2025Jun 30, 2025-$59.98M–
Q1 FY2025Mar 31, 2025-$67.17M–
Q4 FY2024Dec 31, 2024-$33.14M–
Q3 FY2024Sep 30, 2024-$67.17M–
Q2 FY2024Jun 30, 2024-$61.67M-977.9%
Q1 FY2024Mar 31, 2024-$71.47M–
Q4 FY2023Dec 31, 2023-$69.05M–
Q3 FY2023Sep 30, 2023-$64.41M–
Q2 FY2023Jun 30, 2023$7.03M–
Q1 FY2023Mar 31, 2023-$30.59M–
Q4 FY2022Dec 31, 2022-$55.27M–
Q3 FY2022Sep 30, 2022-$87.82M-332.2%
Q2 FY2022Jun 30, 2022-$10.74M-292.8%
Q1 FY2022Mar 31, 2022-$72.42M-288.4%
Q4 FY2021Dec 31, 2021-$63.08M-227.8%
Q3 FY2021Sep 30, 2021$37.83M+72.4%
Q2 FY2021Jun 30, 2021$5.57M-79.5%
Q1 FY2021Mar 31, 2021$38.44M–
Q4 FY2020Dec 31, 2020$49.36M–
Q3 FY2020Sep 30, 2020$21.94M–
Q2 FY2020Jun 30, 2020$27.18M–
Q1 FY2020Mar 31, 2020-$40.76M–
Q4 FY2019Dec 31, 2019-$112.46M–
Q3 FY2019Sep 30, 2019-$39.01M–
Q2 FY2019Jun 30, 2019-$47.26M–
Q1 FY2019Mar 31, 2019-$75.32M–
Q4 FY2018Dec 31, 2018-$90.01M–
Q3 FY2018Sep 30, 2018-$33.46M–
Q2 FY2018Jun 30, 2018-$5.11M–
Q1 FY2018Mar 31, 2018-$42.61M–
Q4 FY2017Dec 31, 2017-$157.63M–
Q3 FY2017Sep 30, 2017-$47.77M–
Q2 FY2017Jun 30, 2017-$25.83M–
Q1 FY2017Mar 31, 2017-$45.22M–
Q4 FY2016Dec 31, 2016-$73.68M–
Q3 FY2016Sep 30, 2016-$23.62M–

More OPKO Health figures

See a number that looks wrong?